Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinicopathologic Conferences

Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma

David L. Bushnell, Mark A. Boles, Gary E. Kaufman, Marie A. Wadas and W. Earl Barnes
Journal of Nuclear Medicine December 1992, 33 (12) 2214-2221;
David L. Bushnell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Boles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary E. Kaufman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie A. Wadas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Earl Barnes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 12
December 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma
David L. Bushnell, Mark A. Boles, Gary E. Kaufman, Marie A. Wadas, W. Earl Barnes
Journal of Nuclear Medicine Dec 1992, 33 (12) 2214-2221;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Complications, Sequela and Dosimetry of Iodine-131 Therapy for Thyroid Carcinoma
David L. Bushnell, Mark A. Boles, Gary E. Kaufman, Marie A. Wadas, W. Earl Barnes
Journal of Nuclear Medicine Dec 1992, 33 (12) 2214-2221;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
  • The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
  • Increasing Efficacy and Safety of Treatments of Patients with Well-Differentiated Thyroid Carcinoma by Measuring Body Retentions of 131I
  • Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
  • Thyroid Carcinoma with High Levels of Function: Treatment with 131I
  • Google Scholar

More in this TOC Section

  • Persistent Fever in a Patient with Polycystic Kidney and Liver Diseases and Bilateral Hip Prostheses
  • Radionuclide Studies of the Upper Gastrointestinal Tract in Children with Feeding Disorders
  • Hypertrophic Cardiomyopathy Complicated with Ventricular Aneurysm and Myocardial Necrosis
Show more Clinicopathologic Conferences

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire